LOS ANGELES, CA — (Marketwired) — 02/02/15 — (OTCQB: MMRF) ("MMR"), a leading provider of (PHRs), storage solutions and electronic document management and imaging systems for , today announced that U.S. Patent No. 8,945,550 will issue on February 3, 2015, providing the second U.S. patent, in addition to patents in Australia, Mexico and South Korea, for the Company–s anti-CD20 monoclonal antibody technology. MMR also announced that it is in talks to sell more than 2,000 patient
LOS ANGELES, CA — (Marketwired) — 09/17/14 — (OTCQB: MMRF) ("MMR" or the "Company") today announced that it has received another significant milestone payment pursuant to an existing Non-Exclusive License Agreement (the "Agreement") pertaining to the Company–s biotech assets. Additional information regarding this milestone payment will be contained in the Company–s quarterly report on Form 10-Q for the quarter ending September 30, 2014. The non-exclusive Agre
LOS ANGELES, CA — (Marketwired) — 08/26/13 — (OTCQB: MMRF) ("MMR"), a leading provider of (PHRs), storage solutions and electronic document management and imaging systems for , today announced that as a result of the Expedited Patent Allowance Program referred to as the Patent Prosecution Highway ("PPH"), and following the issuance of U.S. patents to MMR for its anti-CD20 monoclonal antibodies, the Company has received confirmation of the filings of a divisional applic
